Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Implementation Challenges and Opportunities in Decentralized Methadone Service Delivery

View through CrossRef
Abstract Background: As the burden of opioid use disorder (OUD) increases in low- and middle-income countries, expanding access to medications for opioid use disorder, including methadone maintenance therapy, is essential. Decentralized models of methadone service delivery aim to improve treatment access, reduce costs for clients and burdens on health systems, and deliver more client-centered care. However, questions remain about the feasibility, acceptability, and implementation of decentralized models for methadone delivery, particularly in Africa. We qualitatively examined client and provider perspectives on decentralized methadone service delivery through satellite community health centers in Tanzania. Methods: We conducted a qualitative study with in-depth interviews among 10 providers and four focus groups with 40 participants (clients enrolled in OUD care, outreach workers, and treatment supporters) in Dar es Salaam, Tanzania. Through thematic analysis guided by the Consolidated Framework for Implementation Research (CFIR), we explored the experiences and perceptions of decentralized methadone services, including benefits, barriers, and recommendations. Results: Participants described key advantages of decentralization, such as reduced travel time and costs, improved access for clients with family or work obligations, and less congestion at central specialized opioid treatment clinic. However, they reported challenges across CFIR domains. Under intervention characteristics, clients perceived lower quality of care and less monitoring at satellite community health centers than at specialized opioid treatment clinics. Outer setting factors, such as privacy concerns and stigma, were perceived barriers to decentralized methadone delivery. Compared with specialized clinics, community health centers have fewer wrap-around services, reinforcing perceptions of poor quality of care. Individual characteristics, such as the risk of losing peer support networks and fears of drug testing, further discouraged clients from desiring to be transferred to community health centers. Finally, limited client involvement in planning and unclear communications were viewed as factors contributing to mistrust and resistance among clients to receive their methadone treatment at a community health center. Conclusions: Addressing community stigma, ensuring consistent service quality, supporting and enhancing clients’ social connections, and fostering transparent and participatory planning processes will be critical to effectively implement decentralized methadone service delivery.
Title: Implementation Challenges and Opportunities in Decentralized Methadone Service Delivery
Description:
Abstract Background: As the burden of opioid use disorder (OUD) increases in low- and middle-income countries, expanding access to medications for opioid use disorder, including methadone maintenance therapy, is essential.
Decentralized models of methadone service delivery aim to improve treatment access, reduce costs for clients and burdens on health systems, and deliver more client-centered care.
However, questions remain about the feasibility, acceptability, and implementation of decentralized models for methadone delivery, particularly in Africa.
We qualitatively examined client and provider perspectives on decentralized methadone service delivery through satellite community health centers in Tanzania.
Methods: We conducted a qualitative study with in-depth interviews among 10 providers and four focus groups with 40 participants (clients enrolled in OUD care, outreach workers, and treatment supporters) in Dar es Salaam, Tanzania.
Through thematic analysis guided by the Consolidated Framework for Implementation Research (CFIR), we explored the experiences and perceptions of decentralized methadone services, including benefits, barriers, and recommendations.
Results: Participants described key advantages of decentralization, such as reduced travel time and costs, improved access for clients with family or work obligations, and less congestion at central specialized opioid treatment clinic.
However, they reported challenges across CFIR domains.
Under intervention characteristics, clients perceived lower quality of care and less monitoring at satellite community health centers than at specialized opioid treatment clinics.
Outer setting factors, such as privacy concerns and stigma, were perceived barriers to decentralized methadone delivery.
Compared with specialized clinics, community health centers have fewer wrap-around services, reinforcing perceptions of poor quality of care.
Individual characteristics, such as the risk of losing peer support networks and fears of drug testing, further discouraged clients from desiring to be transferred to community health centers.
Finally, limited client involvement in planning and unclear communications were viewed as factors contributing to mistrust and resistance among clients to receive their methadone treatment at a community health center.
Conclusions: Addressing community stigma, ensuring consistent service quality, supporting and enhancing clients’ social connections, and fostering transparent and participatory planning processes will be critical to effectively implement decentralized methadone service delivery.

Related Results

An Investigation of Medical Examiner Cases in Which Methadone Was Detected, Harris County, Texas, 1987–1992
An Investigation of Medical Examiner Cases in Which Methadone Was Detected, Harris County, Texas, 1987–1992
Abstract In 1991, media reports of an increase in the number of deaths attributed to methadone toxicity in Harris County, Texas, raised public concern about the safe...
Pharmacokinetics and Pharmacodynamics of Methadone Enantiomers After Coadministration with Amprenavir in Opioid‐Dependent Subjects
Pharmacokinetics and Pharmacodynamics of Methadone Enantiomers After Coadministration with Amprenavir in Opioid‐Dependent Subjects
Study Objective. To investigate the steady‐state pharmacokinetics of methadone enantiomers when coadministered with amprenavir.Design. Prospective, open‐label, within‐subject pharm...
Clinical eftects and pharmacokinetics of racemic methadone and its optical isomers
Clinical eftects and pharmacokinetics of racemic methadone and its optical isomers
The respiratory and pupillary effects of oral l‐, d‐, and d,l‐methadone were studied in healthy male volunteers 21 to 35 yr of age. The mean half‐life of drug in blood was 22 hr fo...
Gender‐Specific Differences in Susceptibility to Low‐Dose Methadone‐Associated QTc Prolongation in Patients with Heroin Dependence
Gender‐Specific Differences in Susceptibility to Low‐Dose Methadone‐Associated QTc Prolongation in Patients with Heroin Dependence
Methadone and QT Prolongation. Background: Methadone is associated with QTc prolongation and sudden death in susceptible patients. We sought to investigate whether there is a gende...
Pharmacists' provision of methadone to intoxicated clients in community pharmacies, Victoria, Australia
Pharmacists' provision of methadone to intoxicated clients in community pharmacies, Victoria, Australia
AbstractThis paper concerns pharmacists dispensing methadone to intoxicated clients, drawing on both questionnaire and focus‐group data from a 1996 evaluation of the community‐base...
Improvement of Methadone Maintenance Treatment (MMT) Process Through Development and Implementation of Methadone Dispenser
Improvement of Methadone Maintenance Treatment (MMT) Process Through Development and Implementation of Methadone Dispenser
Abstract Methadone is a controlled drug and can be prescribed by an authorized person in charge, under the direction of medical practitioners, for particular patient...
Cardiac Assessment of Individuals with Opioid Use Disorder under Methadone Treatment
Cardiac Assessment of Individuals with Opioid Use Disorder under Methadone Treatment
Objective: Methadone treatment is effective for managing opioid use disorder (OUD) but raises concerns about its impact on cardiac function. This study aimed to assess ...
First-Line Methadone For Cancer Pain. Titration Time Analysis
First-Line Methadone For Cancer Pain. Titration Time Analysis
Abstract Background. Methadone is a low-cost, strong opioid that is increasingly used as a first-line treatment for pain in palliative care (PC). Its long and unpredictable...

Back to Top